cipla: Cipla in talks to repurpose drugs for Monkeypox, Q1 profit falls 4% to ₹686 cr
Drugmaker on Friday said it is looking at the possibility of partnering with others to repurpose some existing antiviral drugs to treat Monkeypox patients. "We are speaking to a few people, and partners, and we will see what comes out…